Document:

<PAGE>

                                                                   EXHIBIT 10.9

THIS CONTRACT IS ENTERED INTO BY AND BETWEEN:

      BRIDGETECH HOLDINGS INTERNATIONAL, INC. ("DISTRIBUTOR") a corporation
having its principal place of business at: 777 S. Highway 101, Suite 215, Solana
Beach, California 92075

      AND

      SOVEREIGN TRACKING SYSTEMS, L.L.C. ("STS"), a limited liability company,
or its assignee, with its main place of business at: 1108 INDUSTRIAL PARKWAY,
BRICK, NEW JERSEY 08724

      Jointly referred to hereafter as the Parties.

                                    PREAMBLE

      Distributor is in healthcare, medical, clinical & pharmaceutical business.
STS is in the business of offering an asset tracking system (consisting of
hardware and software) that works on radio frequency ("RF") under the trade name
"PALTRACK". PalTrack and its components as well as other related products
designated by STS as available for sale by Distributor are referred to as the
"PRODUCTS". Distributor wishes to purchase from STS the PalTrack System and such
additional Products as may be designated by STS as available for sale, and to
market, re-sell and distribute the Products, subject to the terms and conditions
of this Contract.

      Distributor wishes to license from STS the PalTrack software engine
component of PalTrack presently known as "PALTRACK SOFTWARE ENGINE" for
integration in tracking systems utilizing the PalTrack system and sold by
Distributor ("DISTRIBUTOR'S SYSTEM"), the Distributor's System with the
integrated software being referred to as the "INTEGRATED DISTRIBUTOR'S SYSTEM").
The license granted Distributor under this Contrac, with respect to the PalTrack
Software Engine is sometimes referred to herein as "SOFTWARE LICENSE".

      Distributor has technical expertise in the provision of integrated
solutions and provides its customers with before and after sales support, know
how, specific marketing and integrated solutions. Distributor is a Value Added
Reseller, which is a party with technical expertise, training experience and
market relationships that offer it the ability to properly represent and market
tracking systems incorporating the PalTrack Engine. It is expressly understood
and agreed that any integration of the PalTrack Engine by Distributor into the
PalTrack tracking systems shall be subject to the review and approval of STS in
its sole discretion. It is further understood and agreed that STS is only
granting a license to use the PalTrack Engine in integrations approved by STS
and that ownership of the PALTRACK ENGINE and any enhancements or modifications
thereto shall be and remain with STS, except intellectual property in software
not provided by STS, developed by Distributor allowing for integration into
Distributor's System shall be and remain the property of Distributor.

      The parties have decided to work together to develop market opportunities
based on the Distributor and STS's expertise, in order for the Distributor to
sell. Specifically, the parties contemplate Distributor's resale and
distribution of PalTrack as a stand-alone system.

<PAGE>

      The development, sale or adaptation of Products into other technologies of
Distributor shall be subject to separate agreement between STS and Distributor.
STS shall have sole discretion in approving any suggested application of
Distributor.

      This CONTRACT takes into consideration the above with the purpose of
facilitating relationship between the Distributor and STS.

                                   ARTICLE 1

                                SCOPE OF CONTRACT

      Subject to the terms and limitations of this CONTRACT, STS grants the
Distributor, and Distributor accepts exclusive right to market, sell and
distribute in the "Market" and "Territory" (as such terms are defined below)
PalTrack as a stand-alone system and such other related STS's Products as STS
may determine from time to time. Subject to the terms and limitations of this
Contract, STS grants to Distributor, and Distributor accepts the right to use
and integrate the PALTRACK SOFTWARE ENGINE with DISTRIBUTOR'S SYSTEMS, provided
any integration shall be subject to review, testing and approval of STS, and to
market, sell and distribute the INTEGRATED DISTRIBUTOR'S System in the Market
and Territory. For purposes of this Contract, the Market shall mean hospitals,
doctors offices, medical clinics, nursing homes and similar medical facilities,
but shall not include warehouses, distribution centers, schools and separate
buildings housing administrative offices ("Related Facilities"), even though the
entities using Related Facilities may be the same entities operating the medical
facilities, provided however, that so long as rights have not been afforded to
others with respect to Related Facilities, STS agrees to allow Distributor to
market, sell and distribute the Products to Related Facilities on an
non-exclusive basis. The term Territory shall mean United States of America and
China. The rights hereunder conveyed to Distributor are subject to the terms of
this Contract, including by way of example and not limitation, the payment of
the licensing fee and satisfaction of the minimum purchase requirements as
outlined in ATTACHMENT "A" AND "B". The Distributor has the right to sell the
Products according to the terms and conditions agreed upon between the parties
and stated in the following Articles 2 to 13. Distributor acknowledges that it
may not use the PalTrack Engine for purposes other than in connection with the
sale of the Integrated Distributor System and that it shall not in any event
sell any of the PalTrack Engine other than as part of the Integrated Distributor
System approved by STS.

                                   ARTICLE 2

                                      TERM

      This contract will come into force on latest of the dates of signature by
either party and will expire on July 31, 2010, unless sooner terminated or
extended in accordance with the provisions of this Agreement. Provided
Distributor is in compliance with its obligations under this Contract, this
Contract will automatically renew on a year to year basis thereafter for up to
an additional five (5) years, subject to satisfaction of the minimum purchases
requirements set forth in Attachment "B" for the immediately preceding year,
unless notice of termination is provided by Distributor not less than 120 days
prior to the then applicable expiration date.

                                      -2-

<PAGE>

                                    ARTICLE 3

                        LEGAL POSITION OF THE DISTRIBUTOR

      The Distributor will sell, in its own name and on its own behalf, the
Products, which it purchases from STS. Except as provided herein, installation
shall only be accomplished by STS or parties approved and/or designated by STS,
on terms determined by STS on a case-by-case basis. Upon completion of
Distributor's training pursuant to Article 4.2 and upon STS's determination that
Distributor has demonstrated expertise sufficient to properly market and or
install the Products, the Distributor shall be authorized to perform marketing
and or installation of the Products. As a material inducement to STS's granting
the right to Distributor to perform marketing and or installation, Distributor
shall indemnify and hold STS harmless from any errors, omissions, neglect or
consequences resulting from Distributor's installations, and shall purchase and
maintain for its benefit and the benefit of STS, its principals, agents and
employees, who shall each be named parties insured, GENERAL AND PRODUCT
LIABILITY reasonably satisfactory to STS. Distributor shall provide STS with
evidence that insurance is at all times in place as noted above, delivering any
time upon STS's request and at least annually, not more than thirty (30) days
prior to expiration of policies, certificates of insurance showing the same to
be in place for the following year. Policies shall be with national reputable
insurance companies licensed to do business in all states where installation is
to take place. Policies shall not be cancelable except upon thirty (30) days
written notice to STS. Distributor may not perform installations when insurance
as required hereunder, is not in place to STS's satisfaction.

      Distributor's installations shall be in accordance with guidelines and
procedures established by STS. STS shall sell Products to Distributor at its
then-published wholesale price list, as modified from time to time, on terms set
forth in Article 7 below. STS responsibilities are restricted to those defined
in this contract.

      After acceptance of the present contract by both parties, the Distributor
is authorized to publicly define its activity with the following statements:
"AUTHORIZED SELLER AND DISTRIBUTOR OF PALTRACK" or "Exclusive seller and
distributor of PalTrack to medical facilities". Upon satisfactory completion of
training and delivery of evidence that insurance requirements of STS are met,
Distributor may also represent it as an "AUTHORIZED INSTALLER OF PALTRACK" or
"Exclusive installer of Paltrack to medical facilities".

                                   ARTICLE 4

                          RIGHTS AND OBLIGATIONS OF STS

      4.1 SALES.

      Subject to compliance by Distributor with the terms and conditions of this
Agreement and payment of invoices issued by STS for Products, STS undertakes to
honor orders received and to comply with the delivery periods mutually agreed
upon, subject to Excused Delay.

      When giving quotations, the delivery periods, which vary according to the
type of Product and any customization which may be attached thereto (if agreed
to pursuant to separate

                                      -3-

<PAGE>

agreement) are provided only as an indication by STS of the expected time frame
and are subject to confirmation on a case-by-case basis.

      STS reserves the right to cease or restrict the production and delivery of
any Product and to redesign or modify any Product without incurring obligations
towards the Distributor other than those of meeting purchase orders already
received, provided that: (a) the Distributor will be notified in writing of a
Product withdrawal at least three (3) months in advance, and (b) at the end of
this three (3) months period, the Distributor will be able to send to STS a
"Last Buy Order". Notwithstanding the foregoing, STS can immediately withdraw a
Product in case of, a change required under applicable law, court order or by
STS's attorneys. In such case, any orders outstanding shall be deemed cancelled
or, at the option of Distributor, modified to be for the new or alternative
product recommended by STS then available at a price and upon terms then in
effect for the new or alternative product.

      4.2 TRAINING.

      The signature of this Agreement by the Distributor entitles the
Distributor to technical and commercial training sessions for people
representing both the commercial staff and the technical staff of the
Distributor. Such training sessions shall take place at STS's premises. Any
additional training shall be available at mutually agreeable dates and times.

      The date of the initial training sessions will be fixed by mutual consent.
The training will be organized by STS and at STS's facility. Should the
Distributor wish the initial training sessions be presented on its site, or
should the number of persons the Distributor seeks trained be greater than seven
(7), STS may require additional compensation for training, the terms and
conditions of such training to be furnished by STS in advance for the
Distributor's approval and will include acceptable locations, travel and lodging
expense reimbursement.

      The parties acknowledge that the Distributor's understanding of the
Product, its functions and applications is a material inducement to STS's
continuing into this Agreement and that it is important that the Distributor
remain current in its knowledge. Accordingly, after initial training, STS may
propose future training to the Distributor, on reasonable terms and conditions
to be agreed upon at such time.

      4.3 TECHNICAL SUPPORT.

      STS agrees to assist Distributor by providing a technical hotline service
during regular business hours.

      STS may elect to provide such additional necessary technical support not
provided by Distributor to Distributor and in such case, STS will quote the
price for such technical support according to the needs of the Distributor.

      STS undertakes to keep the Distributor informed of the launching of new
types of Products for which it wishes to entrust sales to the Distributor so
that Distributor can prepare for their installation and sale.

                                      -4-

<PAGE>

      4.4 MARKETING SUPPORT.

      The signature of this Contract by the Distributor entitles the Distributor
to a Welcome Kit consisting of existing marketing materials respecting the
Products. The Welcome Kit will be delivered in the form of a CD. Any updated
promotional materials will be made available to Distributor at STS's cost in the
form of a CD. Distributor shall be responsible for production of such marketing
materials provided by STS on CD. Any desired change to marketing materials shall
be subject to STS approval, not to be unreasonably withheld. STS retains sole
copyright in the Welcome Kit and all other marketing materials produced by STS.

                                   ARTICLE 5

                    RIGHTS AND OBLIGATIONS OF THE DISTRIBUTOR

      5.1 THE DISTRIBUTOR UNDERTAKES TO:

      Provide STS within thirty (30) days signature date of this Agreement or in
case of renewal of this Agreement on the date or before the date of such
renewal, with a business plan (marketing information and plan, sales forecast,
communication plan) and company profile.

      Use STS as the sole source of supply for Products. Distributor shall not
manufacture, distribute nor offer for sale, installation or integration for its
own account or that of others, any product which is competitive with the
Products without the written consent of STS, which may not be unreasonably
withheld. Violation of this covenant shall constitute, at STS's sole election,
an incurable breach allowing, in addition to other remedies, immediate
termination of Distributor's rights to buy and resell or install Products.

      5.2 TRADEMARKS AND LOGO/INDUSTRIAL PROPERTY.

      The Distributor is only entitled to use the specific STS logo for the sale
of Products supplied to the Distributor by STS. This specific logo will be
provided by STS in PC format to which the Distributor shall not make any
modification.

      The Distributor shall not make any reference to, STS, STS's business, its
Products and the relationship between Distributor and STS except through
labeling programs agreed to by the parties and press releases approved by both
STS and Distributor, each party agreeing not to unreasonably withhold such
consent.

      5.3 STOCKS OF PRODUCTS AND DEVELOPMENT SYSTEM SAMPLES.

      In consultation with STS, and with due consideration given to existing and
future estimates of Product orders from Distributor's customers, Distributor
agrees to maintain a sufficient stock of the Products, in order to be able to
rapidly supply its customers.

      To adequately present the STS product to the customer, the distributor
will be provided one STS SAM Demo case. Any additional SAM Demo case purchased
by the distributor will be discounted to $750.00 USD.

                                      -5-

<PAGE>

      5.4 QUALIFICATION OF PERSONNEL.

      The Distributor undertakes to assign qualified personnel to the sale,
service and installation of the Products. Any new persons joining the
Distributor and assigned to the installation of STS's Products shall be trained
by the people who have been trained according to the terms and conditions set
forth in Article 4.2 above.

      5.5 PROMOTION.

      In communication with third parties, the Distributor shall specify that it
is one of STS's distributors. Distributor shall promote the Products and STS,
through its sales force, through exhibitions, web sites, showrooms, press
releases, and brochures, all of which shall be subject to review and approval of
STS, such approval not to be unreasonably withheld.

      5.6 EXCLUSIVE RIGHTS IN HEALTHCARE, MEDICAL, CLINICAL & PHARMACEUTICAL
MARKETS.

      STS will also turn over to Distributor all existing, quoted, and pending
proposals to customers in the Market and Territory, except where to do so would
violate existing agreements STS has with third parties and except where
Distributor does not desire to pursue such matters, in which case Distributor
shall advise STS of its decision within ten (10) days after presentation by STS
of relevant materials concerning such proposals or contracts. Proposals and
contracts so rejected by Distributor may be pursued and/or honored by STS or
third parties designated by STS and shall be deemed excluded from the exclusive
rights granted to Distributor under this Contract. Distributor shall pay STS for
this transfer an initial fee of $50,000 due on contract execution. At this point
in time, the parties anticipate the following accounts will be transferred to
and assumed by Distributor (the obligations and rights respecting the same being
more particularly set forth in Exhibit C attached):

            Advocate Good Shepherd (AGS)
            Holy Name Hospital (HNH)
            Medical University of South Carolina (MUSC)

      Upon execution of this agreement, all other STS distributors who presently
have the right to sell to the Market in the Territory ("Existing Distributors")
must purchase STS Products, including related software from exclusive
Distributor, provided Distributor agrees to honor any price or delivery
commitments made by STS under separate agreements with such Existing
Distributors and provided further that the foregoing requirement that Existing
Distributors source through Distributor shall not apply where the same is
alleged to be a violation of contract.

                                   ARTICLE 6

                                 CONFIDENTIALITY

      In providing its services, each Party will have access to commercial,
financial, technical or strategic information, hereinafter referred to as
"Confidential Information" which shall be treated as confidential.

                                      -6-

<PAGE>

      Each Party gives formal assurance to the other that such Confidential
Information will be safeguarded and will, under no circumstances, be disclosed
to another party without previous approval of the disclosing Party in writing.

      Even after the expiry of this contract, both parties undertake to treat as
strictly confidential any and all Confidential Information received from either
party.

                                   ARTICLE 7

                          PRICE AND PAYMENT CONDITIONS

      The Products will be sold by STS to the Distributor according to its
then-current wholesale price list. STS may impose certain minimum lot per order
purchase requirements provided such are consistently applied to other
distributors and end users contracting with STS directly (except for orders of
samples). Minimum purchaser orders for transmitter tags are in lots of 3,000
units, minimum purchase orders for transceivers are in lots of 250 units, and
such minimum unit amounts are hereafter referred to as "Lots". STS shall have
the right to increase the size of the minimum Lots any time after the second
anniversary of this Contract upon not less than 120 days prior written notice if
STS is advised by manufacturers of the Products of an increase in the minimum
Lot necessary to manufacture the Products or to maintain then existing pricing
or delivery times to STS for the Products.

      The prices and minimum purchase orders of Products sold to Distributor
shall be no higher than the prices or purchase order quantities for any other
STS distributor, reseller or manufacturer of the Products. STS may raise its
prices once every twelve (12) months by giving written notice to Distributor. A
price change shall not be effective as to any purchase made by Distributor
within sixty (60) days after Distributor has received notice of the price
change. Prices cannot increase any more frequently than once every twelve (12)
months from the date of the last price increase.

      STS will invoice the Distributor in US$. Payment arrangements shall be
made 80% of the purchase order due on purchase and balance of 20% due on
delivery to distributor, FOB, STS offices (unless otherwise arranged), Payment
arrangements on any purchase orders over $500,000 US$ shall be made 65% of the
purchase order due on purchase and balance of 35% due on delivery to
distributor, FOB, STS offices (unless otherwise arranged). Payment not made when
due shall be subject to interest at eighteen percent (18%) per annum. STS may
withhold pending orders and/or refuse new orders until past due payments are
made and satisfactory evidence of payment for future orders is provided to STS.

                                   ARTICLE 8

                                    WARRANTY

      Subject to limitations and conditions herein provided, STS warrants to the
Distributor that all PalTrack units sold to Distributor hereunder will be free
from defects in material and workmanship, will conform to all specifications for
the units, and will be fit for the purpose for which they were designed.

                                      -7-

<PAGE>

      STS further warrants that its Products shall comply with their functional
specifications. STS's warranty is strictly limited to the replacement or repair
of the Products (at STS's election) considered as defective by STS.

      STS's warranty is a one year parts valid from the date of installation for
hardware Products requiring installation or from the date on which the hardware
Products are supplied to the Distributor for those hardware Products which do
not require installation, excluding travel and accommodation expenses in the
case of on-site attendance; the Distributor bearing the cost of transportation
of the defective hardware Products in the case of a workshop return. In this
latter case, the defective Products shall be returned to STS in good condition.

      The above warranty does not cover:

      -     Transmitter Tags after they have been delivered, tested and
            installed.

      -     Engineering samples.

      -     Products which have been damaged by the Distributor or any
            third-party or which have been stored under conditions which do not
            comply with STS specifications or normal usage.

      -     Products not integrated (where authorized) or installed properly.

      -     Products submitted to abnormal conditions (mechanical, electrical,
            thermal); abnormal conditions being defined as any conditions
            exceeding the ones stated in the Product specifications.

      -     Products which are incorrectly adjusted or defective when this
            results from use in excessive operating conditions (sundry
            temperatures, voltage and supply limits, electrical or magnetic
            interference) as defined by STS, or from an incorrect choice of
            application (where authorized) by the Distributor or its customers.

      Defective Products must be sent back to STS following STS's return
procedures.

      Distributor shall notify STS of the defects within 15 working days after
the defects are discovered.

THE REMEDY PROVIDED ABOVE IS IN LIEU AND TO THE EXCLUSION OF ALL OTHER REMEDIES,
OBLIGATIONS OR LIABILITIES ON THE PART OF STS FOR DAMAGES, WHETHER IN CONTRACT,
TORT OR OTHERWISE, AND INCLUDING BUT NOT LIMITED TO, DAMAGES FOR ANY DEFECTS IN
THE PRODUCTS OR FOR ANY INJURY, DAMAGE, OR LOSS RESULTING FROM SUCH DEFECTS OR
FROM ANY WORK DONE IN CONNECTION THEREWITH OR FOR CONSEQUENTIAL LOSS, WHETHER
BASED UPON LOSS OF ASSETS, THEFT, LOST GOODWILL, LOST RESALE PROFITS, IMPAIRMENT
OF OTHER GOODS OR ARISING FROM CLAIMS BY THIRD PARTIES OR OTHERWISE. DISTRIBUTOR
ACKNOWLEDGES AND AGREES THAT THE PRODUCTS AND

                                      -8-

<PAGE>

PALTRACK SYSTEM DO NOT CONSTITUTE SECURITY PRODUCTS/SYSTEMS AND ARE NOT DESIGNED
TO PREVENT THEFT, DAMAGE OR VANDALISM TO PERSONS OR PROPERTY. THE PALTRACK
SYSTEM IS DESIGNED TO GENERALLY TRACK MOVEMENT OF ITEMS WITHIN A SPECIFIED AREA,
NOTHING MORE, AND THIS WILL NOT OCCUR UNLESS INSTALLED PROPERLY IN STRICT
ACCORDANCE WITH ALL SPECIFICATIONS OF STS. THIS MAY ALSO NOT OCCUR WHERE THERE
EXISTS INTERFERENCE OR DISRUPTING FACTORS AFFECTING RADIO WAVES. WHILE THE
PALTRACK SYSTEM AND PRODUCTS MAY AID IN SECURITY, THEY DO NOT CONSTITUTE A
SECURITY SYSTEM AND STS MAKES NO REPRESENTATION OR WARRANTY AS TO THE PALTRACK
OR PRODUCTS FUNCTIONALITY OR EFFECTIVENESS AS A SECURITY SYSTEM. DISTRIBUTOR
AGREES TO NOTIFY CUSTOMERS OF THE PROVISIONS OF THIS SECTION, AND THE LIMITATION
OF WARRANTIES AND LIABILITY, HEREIN STATED, AND CUSTOMERS ACKNOWLEDGMENT AND
ACCEPTANCE OF THIS ARTICLE 8 AND AGREEMENT TO LOOK SOLELY TO DISTRIBUTOR FOR ANY
CLAIMS SHALL BE A MANDATORY CONDITION OF SALE.

      STS DISCLAIMS ANY EXPRESS WARRANTY NOT PROVIDED HEREIN AND ANY IMPLIED
WARRANTY, GUARANTY OR REPRESENTATION AS TO PERFORMANCE, QUALITY AND ABSENCE OF
HIDDEN DEFECTS, AND ANY REMEDY FOR BREACH OF CONTRACT, WHICH BUT FOR THIS
PROVISION, MIGHT ARISE BY IMPLICATION, OPERATION OF LAW, CUSTOM OF TRADE OR
COURSE OF DEALING, INCLUDING IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS
FOR A PARTICULAR PURPOSE.

      NO COMPENSATION SHALL BE PAID BY STS IN RESPECT OF DEPRIVATION OF
ENJOYMENT. STS'S ENTIRE LIABILITY, IF INCURRED, WHETHER IN CONTRACT, TORT OR
OTHERWISE, SHALL BE LIMITED TO THE AMOUNT OF THE DEFECTIVE PRODUCT ORDER.

                                   ARTICLE 9

                          INTELLECTUAL PROPERTY RIGHTS

      STS and/or its licensors, as applicable, shall retain title and full
ownership of its Products and technology, and more generally of any industrial
and/or intellectual property rights pertaining to its Products and technology,
including any integration, application, alteration or modification of or
utilization of the Products, regardless of the party performing same, and
regardless whether such was done with STS's consent or performed without STS's
consent in violation of this Agreement.

      Nothing in this Contract shall be construed as granting to the Distributor
or implying any rights, by license, grant or otherwise, under any intellectual
and/or industrial property rights of or concerning any of the Products or any
integration, application modification of or utilizing the Products, regardless
of the party performing same, or information transmitted by STS. No source code
will be transmitted to the Distributor. The Distributor shall not make any
copies,

                                      -9-

<PAGE>

reverse engineer, disassemble, or decompile any Product, any software contained
in or used with any Product or purchased from STS as a stand-alone Product.
Distributor agrees, without charge to STS but at STS's expense, to execute and
deliver all documents necessary, including original applications and
applications for renewal, extension or re-issue of such patents, trademark
registrations or copyright registrations in any and all countries to vest title
in STS or its licensors (as applicable and as their interests may appear), their
successor and assigns.

      The Distributor shall not modify any hardware or software provided by STS
without STS prior written consent. Software incorporated into the Product is
licensed to end users pursuant to separate agreement.

      STS shall place a copy of the source code for related Product software and
firmware in escrow which shall be made available to Distributor for the limited
purposes allowed under this Agreement, in the event that STS declares bankruptcy
or decides to cease all of its business operations.

                                   ARTICLE 10

                                    TRANSFER

      Distributor agrees not to assign, sublicense, transfer or sell any rights
and/or obligations, skills and duties arising from this contract to third
parties, whether by stock sale, merger, asset sale or by operation of law (such
transactions being hereinafter referred to as a "Transfer"), (a change of
control of Distributor also being deemed a Transfer) without prior consent of
STS in writing, which consent, except as otherwise provided herein, may be
withheld in STS's sole discretion. Notwithstanding the foregoing, provided the
following conditions are met, STS agrees not to unreasonably withhold its
consent to the sale of stock or substantially all of a Distributor's assets or a
merger or corporate reorganization, assignment by operation of law or assignment
or transfer of this Agreement to entities under common ownership or control
("affiliates") subject to the following conditions:

      (1)   Distributor or the surviving entity in case of a merger, shall not
            be relieved from any of its obligations under this contract,

      (2)   The Transferee shall assume all of the obligations of Distributor
            under this Agreement from and after the effective date of the
            Transfer by written instrument reasonably acceptable to STS,

      (3)   The Transferee shall have a net worth and credit standing equal or
            greater than that of Distributor as of the date of this Contract or
            the date prior to the effective date of the Transfer, whichever is
            greater,

      (4)   The Transferee shall have experience and skills and engage employees
            and staff sufficient, in STS's reasonable judgment, to perform the
            obligations of Distributor under this Agreement,

                                      -10-

<PAGE>

      (5)   The Transferee shall not be a competitor of STS or use or offer
            competing asset tracking systems that utilize RF technology.

      (6)   Distributor and the proposed Transferee notify STS not less than
            thirty (30) days prior to the proposed effective date of Transfer
            and provide STS with such information as STS may request in order to
            evaluate the request for consent to the Transfer.

      This Agreement is personal to Distributor and entered into based on the
experience, market presence knowledge and representations made by Distributor.
For this reason, Distributor acknowledges that STS may grant or withhold consent
to a transfer in its sole business judgment, except as otherwise provided above.

                                   ARTICLE 11

                             TERMINATION IN ADVANCE

      Notwithstanding the provisions of Article 2 above, STS reserves the right
to terminate this contract upon thirty (30) day written notice in the following
cases:

      (1)   any total or partial transfer by the Distributor of its rights under
            this contract without STS's prior consent in writing.

      (2)   any change in the control of the Distributor which STS considers to
            be against its interests.

      (3)   any sale of competing products that work on RF technology other than
            those stated on Exhibit D attached.

      (4)   the failure of Distributor to satisfy the minimum purchase
            requirements in accordance with Exhibit B.

      (5)   the failure of Distributor to pay the fees and other sums due STS,
            or to otherwise default in its monetary obligations under this
            Contract and Exhibits attached and purchase orders made pursuant to
            or in connection with this Contract, provided STS agrees to afford
            Distributor five (5) days written notice of such failure to pay and
            to cure the failure before the termination shall be deemed
            effective.

      (6)   the default beyond applicable notice and cure period of any other
            agreement between STS, its principals and any other affiliates and
            Distributor, its principals or any other affiliates.

      (7)   any violation of the provisions of Article 9 of this Agreement.

      Each of the Parties also reserves the right to terminate this Contract in
advance and without compensation with notice by registered letter or national
overnight delivery with acknowledgment or refusal of receipt in the case where
the other Party has failed to comply with its non-monetary contractual
obligations and has failed to remedy such breach within a period of

                                      -11-

<PAGE>

thirty (30) days (or such shorter period as reasonable under the circumstances)
or in case of failure to meet its monetary obligations where such breach is not
remedied within five (5) days after written notice of breach. STS shall be
entitled to recover its cost of enforcing its rights under this Agreement
(including reasonable legal fees).

      Each of the Parties reserves the right to terminate this Contract
immediately without the issue of prior notice in the case of any state of
insolvency, receivership or compulsory liquidation of the other Party.

                                   ARTICLE 12

         RULES APPLYING DURING THE EXPIRY OF TERMINATION OF THE CONTRACT

      Except as otherwise agreed in writing by STS, the Distributor must:

      -     Immediately cease using STS's name, address and logo in any form
            whatsoever.

      -     Return to STS, within 30 days of the end of this contract, all
            promotional and advertising documents and materials which may have
            been available for its execution.

      All sums due by the Distributor to STS will be payable within thirty days
from the date of expiry or termination of this Contract.

      No compensation will be due to the Distributor by STS in the case of
expiry or termination of the Contract.

      This Agreement shall be governed by, construed, interpreted and the rights
of the parties determined in accordance with the applicable laws of the United
States and the State of New Jersey, notwithstanding its choice of law rules. The
parties stipulate to the personal and subject matter jurisdiction of the courts
of the State of New Jersey, provided the parties further agree in any litigation
between them, to proceed with non-binding mediation or arbitration prior to
fully litigating its respective claims.

                                   ARTICLE 13

                                  MISCELLANEOUS

      All notices, requests, demands, and other communications shall be in
writing and shall be deemed to have been duly given if personally delivered,
sent by facsimile transmission or overnight courier, or if mailed, by certified
or registered mail, postage paid, to the parties at the following address:

                                      -12-

<PAGE>

      IF TO STS:

              William A. Robinson, President
              Sovereign Tracking Systems LLC
              1108 Industrial Parkway
              Brick, New Jersey  08724

              With a copy (which shall not constitute notice) to:
              Steven M. Abramson, Esquire
              Silver, Freedman & Taff, L.L.P.
              1700 Wisconsin Avenue, N. W.
              Washington, D.C.  20007

      IF TO DISTRIBUTOR:

              Thomas C. Kuhn III, EVP & CFO
              777 South Highway 101
              Suite 215
              Solana Beach, CA  92075

              With a copy (which shall not constitute notice) to:
              Knox Dobbins
              Sutherland Asbill and Brennan
              999 Peachtree Street, NE
              Atlanta, Georgia  30309

                                          SOVEREIGN TRACKING SYSTEMS,
                                          L.L.C., a limited liability company

                                          By: /s/ William A. Robinson
                                              ----------------------------------
                                              William A. Robinson, as Agent Only

                                          Date: 7/27/2005

                                          DISTRIBUTOR: BRIDGETECH
                                          HOLDINGS INTERNATIONAL, INC.

                                          By: /s/ Michael Chermak
                                             -----------------------------------
                                             Name:  Michael Chermak
                                             Title:  CEO
                                             Date:  7/27/2005

                                      -13-

<PAGE>

Rev 3, July 15, 2005 Bridgetech

                                 ATTACHMENT "A"

      Distributor Fee and Minimum Lot Purchase Quantities ("DFMP"). Total DFMP
for the first year of the term is $741,860.00 payable in accordance with the
following:

<TABLE>
<S>                         <C>            <C>
Exclusive Fee               $170,000.00    August 9, 2005
Including yearly PalTrack
Software Engine License

First lot payment           $190,620.00    September 2, 2005
Second lot payment          $190,620.00    December 31, 2005
Third lot payment           $190,620.00    April 30, 2006
</TABLE>

                         All Dollars are in US Currency.

        Exclusive Distributor Fee payment is due on Distributor Contract
                                    execution

                 DFMP payments are due on dates specified above

    Exclusive Distributor Fee payment of $170,000 and is in addition to DFMP
                                   and minimum
                  quantities for such years is due on contract
                                anniversary date
                        On all Subsequent contract years

        DFMP are due on month and day specified above for each subsequent
                                 contract years

          Yearly Software License includes customization and unlimited
                      licensing of PalTrack Software Engine

         First lot payment due September 2, 2005 (production starts once
                              payment is received)

<PAGE>

                                 ATTACHMENT "B"

       Yearly Minimum Purchases from STS Needed to Retain Exclusive Status

                                  Exclusive Fee
                      Annual Distributor Purchase from STS

<TABLE>
<S>              <C>                                  <C>
Initial Year July 19 2005 - July 18, 2006             DFMP (Attachment "A")
Second           Year July 19, 2006 - July 18, 2007   DFMP   +   $758, 140.00
Third            Year July 19, 2007 - July 18, 2008   DFMP   +   $1,258,140.00
Fourth           Year July 19, 2008 - July 18, 2009   DFMP   +   $1,758,140.00
Fifth            Year July 19, 2009 - July 18, 2010   DFMP   +   $2,758,140.00
</TABLE>

Each additional year after the initial term of the contract will require minimum
purchase orders of STS product as listed below:

<TABLE>
<S>              <C>                                  <C>
Out Years        Beyond July 19, 2010                 DFMP   +   $3,258,140.00
</TABLE>

   The above Minimum Purchase Requirements will be increased to reflect actual
     purchases for prior year if greater than amounts stated in chart above.

                         All Dollars are in US Currency.

   Exclusive Distributor Fee payment is due on Distributor Contract execution

              Minimum Lot payments are due on dates specified above

  Exclusive Distributor Fee payment is due on contract anniversary date on all
                           subsequent contract years

     Minimum Lot Payments are due on month and day specified above for each
                            subsequent contract years

 Fee Schedule is based on all purchases made by Distributor from STS, including
  Products, Cabling, Software, Installation, Maintenance Contracts and Training
                                     Costs.

                                      -2-

<PAGE>

                                 Attachment "C"

 Exceptions to STS Existing Hospital Installations, Hospital Quotes, and Ongoing
                                 Revenue Stream

The distributor initially is anticipated to assume the obligations and gain the
benefits under the following customer accounts:

REORDER OF TRANSMITTER

<TABLE>
<CAPTION>
                  Qty               Tag          Sub Total        Margin
                 -----   -----   -----------    -----------    -----------
<S>              <C>     <C>     <C>            <C>            <C>
AGS              2,000     =       $35.00       $ 70,000.00    $ 29,640.00
HNH              2,000     =       $35.00       $ 70,000.00    $ 29,640.00
MUSC             4,000     =       $35.00       $140,000.00    $ 59,280.00
                                 -----------    -----------    -----------
                                      Total     $280,000.00    $118,560.00
                                 -----------    -----------    -----------
</TABLE>

SERVICE/MAINTENANCE CONTRACT

The following hospitals will require a 4-Year Service/Maintenance Contract that
has not been established at this time.

The 4-year Maintenance contract is as follows:

<TABLE>
<S>              <C>          <C>               <C>
AGS              $44,595      Initial Total     $133,785
HNH              $44,595
MUSC             $44,595

Transferring Fee = $50,000
</TABLE>

                                      -3-<PAGE>

                                                                   EXHIBIT 10.10

                            COURSE CONTENT AGREEMENT
                                     BETWEEN
                           INTERNATIONAL MEDLINK, INC.
                                       AND
                              VANDERBILT UNIVERSITY

      This Course Content Agreement ("Agreement") is entered into as of February
4, 2005 ("Effective Date") by and between International MedLink, Inc., a Texas
corporation with its principal place of business at 2400 Crestmoor Road,
Nashville, TN 37215 ("IML") and Vanderbilt University, a Tennessee
not-for-profit organization, by and through its Vanderbilt University School of
Nursing, with its principal place of business at 211 Godchaux Hall, Nashville,
TN 37232, ("Vanderbilt").

      WHEREAS, IML is in the business of recruiting nurses trained in the
Philippines to become employees of hospitals and other health care facilities
located in the United States, and has or will enter into contracts with such
health care providers for placement of such nurses;

      WHEREAS, IML has employed instructors to work in facilities provided by
St. Louis Review Centers, Inc. ("SLRC") to train nurses in the Philippines in
order to prepare such individuals for career opportunities outside of their
native countries, and, in particular, to prepare them to take the Qualifying
Exam of the Commission on Graduates of Foreign Nursing Schools ("CGFNS Exam")
and the National Council Licensure Examination for Registered Nurses
("NCLEX-RN");

      WHEREAS, Vanderbilt has the capability and expertise to develop course
content on topics relevant to preparation of nurses for the NCLEX-RN, and IML
desires for Vanderbilt to provide such course content in lecture format on
videotape for IML to provide to its employees for use in training nurses in the
Philippines, and Vanderbilt is willing to provide such course content on the
terms and conditions set forth in this Agreement;

      NOW, THEREFORE, for and in consideration of the mutual covenants and
promises contained herein, the receipt and sufficiency of which are hereby
acknowledged, IML and Vanderbilt hereby agree as follows:

1 DEFINITIONS

1.1   "IML Training Program" - shall mean the educational program designed and
      delivered by IML to train nurses at SLRC Centers located in the
      Philippines to prepare them for placement in nursing jobs in the United
      States, including preparation for the CGFNS Exam and NCLEX-RN Exam. The
      IML Training Program shall only be delivered to nurses for whom IML is
      contractually obligated to provide such training, and only by instructors
      employed by IML.

<PAGE>

1.2   "SLRC Center" - shall mean those locations in the Philippines at which IML
      shall provide training to nurses.

1.3   "Vanderbilt Certification" - shall refer to the issuance by Vanderbilt of
      a certificate for each student who has completed a Vanderbilt Course, as
      certified to Vanderbilt by IML.

1.4   "Vanderbilt Courses" - shall mean courses developed by Vanderbilt faculty
      members and delivered in conventional lecture format via videotape, which
      courses shall be designed to assist instructors of nurses in preparation
      for the NCLEX-RN.

1.5   "Vanderbilt Materials" - shall mean course syllabi, reading materials,
      exercises, references, handouts and other written content developed by
      Vanderbilt faculty members that relate to the Vanderbilt Courses and are
      to be used by students in connection with the Vanderbilt Courses.

2 COURSE DEVELOPMENT AND LICENSE

2.1   Courseware Development. Vanderbilt shall develop Vanderbilt Courses and
      Vanderbilt Materials for inclusion in the IML Training Program to be
      delivered by instructors employed by IML to work at SLRC Centers located
      in the Philippines. Vanderbilt and its faculty members shall determine
      appropriate content for the Vanderbilt Courses and the Vanderbilt
      Materials in their sole discretion.

2.2   Delivery of Vanderbilt Courses and Materials. On or before April 1, 2005,
      Vanderbilt shall deliver videotapes to IML containing the Vanderbilt
      Courses, along with associated Vanderbilt Materials. Vanderbilt shall not
      be liable for delay or failure of performance of any of its obligations
      pursuant to this Agreement if such delay or failure is due to causes
      beyond its reasonable control, including without limitation, acts of God,
      fires, earthquakes, strikes and labor disputes, acts of war or terrorism,
      civil unrest or intervention of any governmental authority, but any such
      delay or failure shall be remedied as soon as reasonably practicable.

2.3   Training of Instructors. Vanderbilt shall provide three (3) days annually
      during normal business hours of training time to be delivered to
      instructors who are employed by IML to teach each the IML Training
      Program, subject to Vanderbilt's approval as to scheduling of such
      training and provided that IML shall reimburse Vanderbilt as set forth in
      Section 5.3 below. The training shall cover subject matter contained
      within the Vanderbilt Courses and Vanderbilt Materials. IML shall be
      responsible to assure, and hereby represents and warrants, that all
      instructors who are engaged to teach the Vanderbilt Courses and use the
      Vanderbilt Materials have, and will continue to have during the term of
      this Agreement, sufficient knowledge, background, skills, and
      qualifications to actively participate in and understand the subject
      matter training, and to teach the

                                       2

<PAGE>

      Vanderbilt Courses and Vanderbilt Materials. IML will assure, and hereby
      represents and warrants, that all instructors engaged to teach the
      Vanderbilt Courses and use the Vanderbilt Materials now and at all times
      during the term of this Agreement shall meet the criteria, standards and
      requirements of all applicable United States and Philippines accrediting
      bodies and governmental agencies or authorities, and IML shall hold
      harmless and indemnify Vanderbilt against any and all alleged or actual
      claims, damages, loss, liability or expense in connection with the acts or
      omissions of IML, SLRC, and their respective officers, directors,
      employees, agents, independent contractors and instructors in connection
      with the delivery of the Vanderbilt Courses and Vanderbilt Materials or
      otherwise.

2.4   License. Vanderbilt hereby grants to IML and IML hereby accepts from
      Vanderbilt, upon the terms and conditions herein specified, a limited
      exclusive license to use the Vanderbilt Courses and Vanderbilt Materials
      solely in connection with the IML Training Program in the Philippines for
      the purposes set forth in this Agreement. The license granted herein shall
      be limited solely to use in traditional classroom learning environments
      operated within SLRC Centers and located within the Philippines and shall
      not extend to use, display or distribution of the Vanderbilt Courses or
      Vanderbilt Materials via the Internet or any other distance learning
      application. Vanderbilt shall retain all right, title and interest in and
      to the Vanderbilt courses and Vanderbilt Materials and all content
      therein, and shall hold all right, title and interest in and to any
      modifications or improvements made to the Vanderbilt Courses and
      Vanderbilt Materials, or other derivative works. All rights not granted
      herein are explicitly reserved to Vanderbilt.

2.5   No Sublicense. IML shall have no right to assign, transfer or convey any
      of the rights granted pursuant to this Agreement.

2.6   Certification. For each student for whom IML certifies in writing to
      Vanderbilt that such student has completed a Vanderbilt Course in good
      standing as part of the IML Training Program, Vanderbilt shall issue a
      Vanderbilt Certification acknowledging completion of the Vanderbilt
      Course. IML shall hold harmless and indemnify Vanderbilt and all alleged
      or actual claims, damages, loss, liability or expense in connection with
      certifications mistakenly issued as a result of any inaccurate information
      provided by IML to Vanderbilt regarding such student's completion of the
      Vanderbilt Course.

2.7   No Representation or Warranty. VANDERBILT MAKES NO REPRESENTATION OR
      WARRANTY OF ANY KIND EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION, ANY
      REPRESENTATION OR WARRANTY REGARDING THE VANDERBILT COURSES OR THE
      VANDERBILT MATERIALS. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING,
      VANDERBILT MAKES NO REPRESENTATION OR WARRANTY REGARDING THE TRAINING OF
      NURSES WHO TAKE THE VANDERBILT COURSES, THE ADEQUACY OF THE VANDERBILT

                                       3

<PAGE>

      COURSES AND VANDERBILT MATERIALS TO PREPARE STUDENTS FOR THE CGFNS EXAM
      AND NCLEX-RN EXAM, OR THE PERFORMANCE OF NURSES ON SUCH EXAMS OR IN THE
      WORKPLACE. VANDERBILT HEREBY DISCLAIMS ALL WARRANTIES EXPRESS AND IMPLIED
      INCLUDING WITHOUT LIMITATION, ANY IMPLIED WARRANTY OF MERCHANTABILITY OR
      IMPLIED WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE.

3 OBLIGATIONS OF IML

3.1   Development of IML Training Program. At its sole cost and expense, IML
      shall design, develop, and implement all aspects of the IML Training
      Program including without limitation (i) assuring the establishment and
      availability of SLRC Centers within the Philippines suitable for
      conducting the IML Training Program; (ii) marketing the IML Training
      Program to prospective students, and handling all aspects of enrollment
      and registration of students; (iii) all technical aspects of the IML
      Training Program, including without limitation, all infrastructure and
      equipment, facilities, hardware, software and services necessary or
      appropriate to assure timely and accurate delivery and display of the
      Vanderbilt Courses, Vanderbilt Materials and other aspects of the IML
      Training Program; (iv) all financial aspects of the IML Training Program,
      including without limitation, providing appropriate capitalization to
      develop, implement and conduct the IML Training Program, entering into
      contracts with students and prospective employers, collection of tuition,
      tuition payment arrangements, payment of all teaching, technical and other
      staff; (v) responsibility for all academic and student matters, including
      without limitation, teaching and preparation of students in speaking,
      reading and writing English assuring that students have passed the CGFNS
      Exam prior to delivery of the Vanderbilt Courses and Vanderbilt Materials,
      scheduling of courses, distribution of necessary information and materials
      to students and responding to student complaints or requests for
      information or academic consultation, admission of students to the IML
      Training Program, grading and evaluation of students, hiring of trained
      faculty and other professionals to teach students enrolled in the IML
      Training Program, disciplinary actions and preparation of students for the
      CGFNS Exam and NCLEX-RN Exams; (vi) responsibility for all career
      counseling and placement arrangements for students, and all agreements
      with prospective employers or other organizations relating to placement of
      students.

3.2   Marketing. IML shall use its best efforts to market the IML Training
      Program to students and prospective employers, and to enter into contracts
      with respect to enrollment of students in the IML Training Program. IML
      shall not market the IML Training Program in any manner whatsoever that
      would suggest or imply that such program is a Vanderbilt program or that
      it is sponsored or endorsed by Vanderbilt, it being the understanding of
      the parties hereto that Vanderbilt is not responsible for the delivery of
      the IML Training Program and that such program is independent from the
      academic programs of Vanderbilt. IML shall not use the Vanderbilt name in
      any marketing within the Philippines. IML may refer to

                                       4

<PAGE>

      Vanderbilt Courses and Vanderbilt Materials in its marketing materials to
      prospective employers in the United States, provided that IML shall obtain
      in the prior written approval of Vanderbilt, acting through its Associate
      Vice Chancellor, VUMC Communications, as to such marketing materials.

3.3   Compliance with Law; Accreditation. IML hereby covenants that: it shall
      comply with, and shall assure that SLRC complies with, the licensure
      requirements, guidelines, laws, rules, regulations, orders, decrees, and
      treaties of, by or between, any governmental body having jurisdiction
      within or outside the Philippines, including without limitation, all
      guidelines and resolutions issued or promulgated by the Professional
      Regulation Commission and the Board of Nursing of the Philippines pursuant
      to the Philippine Nursing Act of 1991, as amended, and the Philippine
      Nursing Act of 2002 ("Applicable Law"), and with the standards, policies
      and procedures of any applicable accrediting body or agency having
      jurisdiction over Vanderbilt, IML or any activity contemplated by
      Agreement.

4 REPRESENTATIONS, WARRANTIES AND COVENANTS OF IML

      IML hereby represents, warrants and covenants to Vanderbilt, intending
that Vanderbilt rely thereon, as follows:

4.1   IML is a corporation, duly incorporated and validly existing under the
      laws of the State of Texas. SLRC is a corporation, duly incorporated and
      validly existing under the laws of its incorporation.

4.2   Each of IML and SLRC are, and throughout the term will remain, licensed to
      do business in the Philippines. IML and SLRC are in compliance with
      Applicable Law, and have each received, and shall have a continuing
      obligation to obtain, all necessary consents, authorizations and approvals
      of, and to make any filings required by, Applicable Law or any governing
      body or agency or accrediting body having authority over the delivery of
      services and operation of the IML Training Program as contemplated by this
      Agreement.

4.3   IML has the full right, power and authority to enter into, and to perform
      its obligations under this Agreement. This Agreement has been duly and
      validly authorized, executed and delivered by IML and constitutes the
      valid and binding obligation of IML, enforceable in accordance with its
      terms.

4.4   The execution and delivery of this Agreement, the consummation of the
      transactions herein contemplated, and the compliance with the terms of
      this Agreement, will not conflict with or result in a breach of any of the
      terms or provisions of or constitute a default under, any contract,
      agreement or instrument to which IML or SLRC is a party or by which IML or
      SLRC is bound, or any Applicable Law or any judgment, order or decree of
      any court or tribunal having jurisdiction over IML or SLRC.

                                       5

<PAGE>

5 COMPENSATION

5.1   Compensation. As consideration for the license granted hereby, IML will
      pay to Vanderbilt the following royalties:

      5.1.1 Upfront Fees. IML shall pay to Vanderbilt Twenty Thousand Dollars
            ($20,000) on March 15, 2005.

      5.1.2 Completion of IML Training Program. IML shall pay to Vanderbilt Five
            Hundred Dollars ($500.00) per student for each student enrolled in
            the IML Training Program who completes the Vanderbilt Coursework.
            Such payment shall be due and payable not later than fifteen (15)
            days following the end of each Vanderbilt Course during the term
            hereof.

      5.1.3 NCLEX-RN Exam. IML shall pay to Vanderbilt Five Hundred Dollars
            ($500.00) per student for each student enrolled in the IML Training
            Program who passes the NCLEX-RN Exam. Such payment shall be due and
            payable not later than fifteen (15) days following the receipt of
            notification that a student has passed the NCLEX-RN Exam.

5.2   Guaranteed Minimum Payment. Notwithstanding anything herein to the
      contrary, in regard to the payments due pursuant to Section 5.1 above, IML
      guarantees to Vanderbilt a minimum of Fifty Thousand Dollars ($50,000.00)
      during the first year of this Agreement and a minimum of One Hundred
      Thousand Dollars ($100,000.00) during the second year of this Agreement.

5.3   Cost Reimbursement. IML shall pay Vanderbilt's reasonable out-of-pocket
      costs incurred in connection with training activities provided pursuant to
      Section 2.3 of this Agreement, including without limitation, costs
      incurred for travel, meals, lodging and similar expenses. Vanderbilt shall
      submit invoices to IML for all such costs, and INC shall remit payment to
      Vanderbilt within thirty (30) days of receipt of invoice.

5.4   Payment. All payments due pursuant to this Agreement shall be made when
      due, without offset or deduction, by check made payable to Vanderbilt
      University and sent to Vanderbilt University Medical Center, Mr. Stephen
      Todd, Associate Director of Academic Research and Enterprise, Department
      of Finance, Dept AT 40303, Atlanta, GA 31192-0303.

5.5   Audit Rights. IML will provide Vanderbilt, at no cost to Vanderbilt, with
      monthly reports of numbers of students enrolled in the IML Training
      Program. Vanderbilt shall have the right to audit the financial books and
      records of IML and SLRC in order to verify the amounts due to Vanderbilt
      under this Agreement. Such audit shall be conducted at Vanderbilt's
      expense, except that IML shall be obligated to reimburse Vanderbilt for
      the full cost and expense of any audit that reveals an underpayment of
      compensation due to Vanderbilt pursuant to this Agreement of five percent
      (5%) or more. IML shall, and shall cause SLRC to, maintain and keep
      available their respective books and records for inspection by

                                       6

<PAGE>

      Vanderbilt at any time during the term of this Agreement and for two (2)
      years thereafter.

5.6   Reporting. IML shall develop tools for evaluation of the IML Training
      Program, including without limitation, performance data for students
      enrolled in the IML Training Program, employer satisfaction surveys, and
      student satisfaction surveys. IML shall prepare, keep and maintain reports
      setting forth the results of such evaluations, and shall provide the same
      to Vanderbilt from time to time upon request.

6 TERM AND TERMINATION

6.1   Term. The term of this Agreement shall be two (2) years and shall commence
      on April 1, 2005 and terminate on March 31, 2007. This Agreement may be
      extended for additional one (1) year terms by mutual written agreement
      signed by the parties hereto.

6.2   Termination. This Agreement may be terminated as follows:

      6.2.1 If, for any reason, either party fails to satisfactorily fulfill in
            a timely or proper manner its obligations under this Agreement or
            breaches any of the promises, terms or conditions of this Agreement
            without having cured such breach to the satisfaction of the
            non-breaching party within thirty (30) days of written notice of
            default by the non-defaulting party, or, in the case of a failure to
            make payment when due, within ten (10) days of written notice of
            default by the non-breaching party, the non-breaching party shall
            have the right to terminate this Agreement immediately upon written
            notice to the other party.

      6.2.2 Either party to this Agreement shall have the right to terminate
            this Agreement without cause by giving written notice to the other
            party of such termination pf at least thirty (30) calendar days
            before the effective date of such termination. For termination of
            any type, any other provision to the contrary notwithstanding, the
            breaching party shall not be relieved of liability to the
            non-breaching party for damages sustained because of any breach of
            this Agreement.

      6.2.3 In the event that either party shall become insolvent or make a
            general assignment for the benefit of creditors, the other party may
            terminate this Agreement immediately upon written notice to the
            party undergoing such insolvency or general assignment.

      6.2.4 In the event that either party sells all or substantially all of its
            assets, there is a sale of a majority ownership of either party, or
            there occurs a material change in management or ownership of either
            party (each, a "Change in Control"), the other party may terminate
            this Agreement immediately upon written notice to the party
            undergoing such Change in Control.

                                       7

<PAGE>

6.3   Effect of Termination. Immediately upon termination of this Agreement IML
      shall cease use of the Vanderbilt Courses, the Vanderbilt Material, and
      the use of the Vanderbilt name in connection with any marketing activities
      or otherwise. Immediately upon termination of this Agreement, all rights
      of IML shall revert to Vanderbilt, and IML, at its sole cost and expense,
      shall return all Vanderbilt Courses and Vanderbilt Materials in its
      possession to Vanderbilt and shall so certify in writing to Vanderbilt.
      IML shall be liable Vanderbilt for any payments due through the date of
      termination of this Agreement and, following termination, for payments
      subsequently due pursuant to Sections 5.1.2-5.1.3 hereof for students who
      are enrolled in the IML Training Program as of the date of termination of
      this Agreement.

7 INDEMNIFICATION AND INSURANCE

7.1   Indemnification. In addition to the indemnities provided by IML pursuant
      to Sections 2.3 and 2.6 above, IML shall indemnify and hold harmless
      Vanderbilt, its officers, directors, employees and agents (each, a
      "Vanderbilt Indemnitee") from and against any damage, loss, liability,
      fine, penalty, charge, administrative or judicial proceeding or order,
      judgment, enforcement action of any kind, cost or expense (including
      reasonable attorneys' fees and legal expense) incurred by or imposed upon
      any Vanderbilt Indemnitee in connection with any claims, suits, actions,
      demands or judgments arising out of any theory of law (including, but not
      limited to, actions in the form of tort, warranty, or strict liability)
      resulting from or arising out of (i) any breach of IML's obligations or
      covenants pursuant to this Agreement, (ii) any inaccurate representation
      or warranty made by IML pursuant to this Agreement, (iii) the operations,
      business, contracts, or activities of IML or SLRC or any of their
      respective employees, instructors, or independent contractors relating to
      the IML Training Program or otherwise, including without limitation,
      claims by students, employers or instructors of any nature whatsoever,
      (iv) any breach of IML's or SLRC's obligations or covenants pursuant to
      any agreement with a prospective employer involving the placement,
      qualifications, or conduct of students, or (v) any act or omission by IML,
      SLRC or any of their respective officers, directors, employees,
      independent contractors, instructors or agents.

7.2   Insurance

      7.2.1 Both parties shall maintain for the term of this Agreement
            comprehensive general liability insurance, including broad form
            contractual in a minimum amount of $1,000,000/$3,000,000. The
            coverage shall bear an endorsement precluding cancellation or
            reduction of coverage.

      7.2.2 Both parties shall procure and maintain for the term of this
            Agreement professional liability insurance, in a minimum amount of
            $1,000,000/$3,000,000 in coverage for all of its personnel who may
            participate in this Agreement. Such coverage shall be for a minimum
            of five (5) years following expiration or termination of this
            Agreement and

                                       8

<PAGE>

            shall provide for a retroactive date no later than the inception
            date of this Agreement.

      7.2.3 IML shall also procure and maintain general liability insurance
            meeting the requirements of Section 7.2.1 above covering risk
            associated with SLRC's operations as they relate to the IML Training
            Program.

      7.2.4 Each party shall provide the other party with Certificates of
            Insurance evidencing the above coverage. The coverage shall bear an
            endorsement precluding cancellation or reduction of coverage.

      7.2.5 Any insurance coverage required of Vanderbilt as stated above may be
            provided through a program of self-insurance.

7.3   Notification of Claims. IML agrees to notify Vanderbilt as soon as
      possible in writing of any incident, occurrence, or claim arising out of
      or in connection with this Agreement which could result in a liability or
      claim of liability to Vanderbilt. Vanderbilt shall have the right to
      investigate said incident or occurrence and IML will cooperate fully in
      this Investigation.

8 CONFIDENTIALITY

8.1   Treatment of Confidential Information. It may be necessary for one party
      to disclose to other party certain confidential or proprietary
      information, which is identified by the disclosing party as
      "confidential." In such event, the receiving party agrees to preserve such
      identified information as confidential. The obligation of confidentiality
      shall not apply to information which:

      8.1.1 is now in the public domain or which becomes generally available to
            the public through no fault of the receiving party; or

      8.1.2 is already known to, or in the possession of, the receiving party
            prior to disclosure by the disclosing party as can be demonstrated
            by documentary evidence; or

      8.1.3 is disclosed on a non-confidential basis from a third party having
            the right to make such a disclosure; or

      8.1.4 is independently developed by the receiving party (by activity not
            associated with the rights licensed hereunder) as can be
            demonstrated by documentary evidence; or

      8.1.5 is required to be disclosed by law or government authority.

9 MISCELLANEOUS

9.1   Use of Vanderbilt Name. IML agrees not to identify Vanderbilt or to use
      the name of Vanderbilt, its faculty, trustees, officers, employees, or
      students, or any

                                       9

<PAGE>

      trademark, service mark, trade name, or symbol of Vanderbilt, or that is
      associated with any of them, promotional advertising, marketing, or other
      similar materials without Vanderbilt's prior written consent, acting
      through its Associate Vice Chancellor, VUMC Communications. It is agreed
      that IML shall not seek to refer to Vanderbilt in any materials within the
      Philippines. As to marketing materials to be used in connection with IML's
      placement activities within the United States, IML shall seek prior
      written consent for any references in such materials to Vanderbilt, in
      accordance with the provisions of this Section 9.1.

9.2   Notices. All notices or other communications provided for in this
      Agreement shall be given to the parties addressed as follows:

                             IML:      Evans M. Clements III
                                       International MedLink, Inc.
                                       2400 Crestmoor Road
                                       Nashville, Tennessee 37215

                        Vanderbilt:    Linda Norman, Associate Dean
                                       Vanderbilt School of Nursing
                                       201 Godchaux Hall
                                       Nashville, TN 37232

                                       Mr. Steve Todd
                                       Director of Finance and Administration
                                       School of Medicine
                                       Vanderbilt University
                                       CCC-3315 Medical Center North
                                       Nashville, TN 37232-2104

                    with copies to:    Vanderbilt University
                                       Office of Grants and Contracts Management
                                       3319 West End Avenue, Suite 100
                                       Nashville, TN 37203-6869

                                       Vanderbilt University
                                       Office of the General Counsel
                                       2100 West End Avenue, Suite 750
                                       Nashville, TN 37203
                                       Attention: Julia S. Faber

9.3   Survival. The terms and provisions of Articles 7 and 8 hereof shall
      survive the expiration or termination of this Agreement.

9.4   Assignment and Binding Effect. Neither party shall assign, subcontract, or
      transfer any of its rights or obligations under this Agreement to a third
      party without the prior written consent of the other party. If an
      assignment, subcontract, or transfer of rights does occur in accordance
      with this Agreement, this

                                       10

<PAGE>

      Agreement shall be binding upon and inure to the benefit of the parties
      hereto and their respective successors or assigns.

9.5   Independent Contractor. Each party shall be considered to be an
      independent contractor and shall not be construed to be an agent or
      representative of the other party, and therefore, shall have no liability
      for the acts or omissions of the other party. In addition, neither party,
      nor any of its employees, agents, or subcontractors, shall be deemed to be
      employees or agents of the other party. Therefore, neither party, nor any
      of its employees, agents or subcontractors, shall be entitled to salary,
      workers compensation, or employee benefits of the other party by virtue of
      this Agreement.

9.6   Written Amendments and Waiver. This Agreement cannot be amended, modified,
      supplemented or rescinded except in writing signed by the parties hereto.

9.7   Governing Law and Jurisdiction. This Agreement shall be governed in all
      respects by, and be construed in accordance with, the laws of the State of
      Tennessee. Each party hereby consents to the jurisdiction of all state and
      federal courts situated in Davidson County, Tennessee, agrees that venue
      for any such action shall lie exclusively in such courts, and agrees that
      such courts shall be the exclusive forum for any legal actions brought in
      connection with this Agreement or the relationships among the parties
      hereto.

9.8   Entire Agreement. This Agreement constitutes the entire agreement between
      the parties hereto with respect to the subject matter herein and
      supersedes any other agreements, restrictions, representations or
      warranties, if any, between the parties hereto with regard to the subject
      matter herein.

9.9   Severability. If any provision of this Agreement shall be held by a court
      of competent jurisdiction to be illegal, invalid, or unenforceable, the
      remaining provisions shall remain in full force and effect.

9.10  No Waiver. No waiver of any breach of any provision of this Agreement
      shall constitute a waiver of any prior, concurrent or subsequent breach of
      the same or any other provisions hereof, and no waiver shall be effective
      unless made in writing and signed by an authorized representative of the
      waiving party.

9.11  Headings. The Article headings used in this Agreement are intended for
      convenience only and shall not be deemed to supersede or modify any
      provisions.

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                       11

<PAGE>

      IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
executed by their duly authorized representatives and thereby become effective
on the date specified above.

FOR INTERNATIONAL MEDLINK, INC.

/s/ Evans M. Clements, III                                  01/25/05
------------------------------------------
Name: Evans M. Clements, III                             Date
Title: CEO
FOR VANDERBILT UNIVERSITY

Recommended by:

/s/ Linda D. Norman                                        01/31/05
--------------------------------------------
Linda D. Norman                                          Date
Senior Associate Dean, School of Nursing

Approved by:

/s/ Jeff Kaplan                                            02/04/05
--------------------------------------------
Jeff Kaplan                                               Date
Associate Vice Chancellor for Health Affairs

                                       12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00095-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00095-of-00352.parquet"}]]